BioMarin Pharmaceutical Inc. buy Wolfe Research
Start price
15.07.25
/
50%
€49.93
Target price
15.07.26
€81.42
Performance (%)
-9.07%
Price
12.12.25
€45.40
Summary
This prediction is currently active. With a performance of -9.07%, the BUY prediction for BioMarin Pharmaceutical Inc. by Wolfe_Research is down slightly. This prediction currently runs until 15.07.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -1.003% | -1.003% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Wolfe_Research for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was given a new $95.00 price target on by analysts at Wolfe Research. They now have an "outperform" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Wolfe_Research for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€60.78
15.11.24
15.11.24
€89.95
15.11.25
15.11.25
-22.26%
16.11.25
16.11.25
